June 8, 2023

Hardwood Paroxysm

All Latest News For You!

How can innovative medicines be identified and made available? It is discussed in the Academy of Sciences – UniboMagazine

For the “Against Pseudoscience” course, an appointment with Nicola Magrini, Director of the Quality and Clinical Governance Unit in Romania Osl, to get an overview of the current dynamics and to reflect on the tools available at the global, national and local level, market defense policies, competition, overall sustainability of healthcare systems and more a lot

will take place Thursday, April 20, at 17.00at the Academy of Sciences of the Bologna Institute (Via Zamboni, 31), meeting “Innovative medicines. between science, politics and ethicsWith Dr. Nicola Magrini. Appointment to Course “Against pseudoscience” Organized by the Academy of Sciences to understand what can be the tools to counter the phenomenon of the spread of pseudoscientific information and the general distrust of science by large sectors of the population.

doctor. Negrini will reflect on youA subject of exceptional importance as made clear during the recent Covid-19 pandemic, When innovation in various fields (drugs, vaccines, diagnostics) was immediately recognized and made widely available in a short time, new research platforms for comparative clinical studies were created to understand the true value of some of the available drugs. Examples of important innovations and mechanisms to facilitate access to and sustain the National Health Service occurred in Italy With special price agreements for sofosbuvir in the treatment of hepatitis C and more recently for cystic fibrosis drugs.

To provide an overview of the current dynamics and possible solutions to facilitate access, The different tools available at the global, national and local levels will be reviewed market defense and competition policies as well as the overall sustainability of healthcare systems. Some new antibiotics against multi-resistant bacteria will be studied in depth for which new conventions should be assumed to reduce their use and encourage research. It will also reflect on the post-Covid-19 transition from an ethic based on respect for the individual to an ethic not only of public health but global, linking and integrating OneHealth-related problems with climate change and the implications for public health systems.

See also  Luca Ricolfi, the science veneer No-Vax needs to challenge vaccines

Nicholas Magrini He is currently the Director of the Quality Operational and Clinical Governance Unit at Romagna Ausl, having served as Secretary of the WHO List of Essential Medicines (2014-2020) and Director General of the Italian Medicines Agency from March 2020 to January 2023.